Algert Global LLC Repligen Corp Transaction History

Algert Global LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$160.42 - $256.21 $1.34 Million - $2.14 Million	8,352 Added 67.45%	20,734 $3.88 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $306,682 - $409,883	-2,180 Reduced 14.97%	12,382 $2.01 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $1.18 Million - $1.89 Million	7,336 Added 101.52%	14,562 $2.74 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $248,580 - $305,687	-1,004 Reduced 12.2%	7,226 $1.91 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $1.25 Million - $2.08 Million	6,411 Added 352.45%	8,230 $2.38 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $1.39 Million - $1.86 Million	-8,397 Reduced 82.19%	1,819 $363,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $830,603 - $1.04 Million	4,605 Added 82.07%	10,216 $1.99 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $830,876 - $1.16 Million	5,611 New	5,611 $1.08 Million
Q4 2019 Feb 18, 2020	SELL	$73.84 - $93.08 $1.52 Million - $1.91 Million	-20,550 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $107,463 - $133,905	-1,402 Reduced 6.39%	20,550 $1.58 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $531,702 - $843,169	-9,810 Reduced 30.89%	21,952 $1.89 Million
Q1 2019 May 01, 2019	BUY	$49.45 - $62.8 $291,062 - $369,640	5,886 Added 22.75%	31,762 $1.88 Million
Q4 2018 Feb 01, 2019	BUY	$48.26 - $68.88 $1.25 Million - $1.78 Million	25,876 New	25,876 $1.37 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.